Perry et al. [76] studied that gut microbiota-nutrient interaction in HFD-fed rodents contributed to the increased glucose-stimulated insulin secretion ghrelin secretion, obesity and its related sequelae of hyperlipidaemia, which is a possible therapeutic target for obesity. The gene discussed is GHRL; the disease is obesity disorder.